0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Treatment of Borderline Elevated Thyrotropin Levels—Reply

Peter N. Taylor, MSc, MRCP1; Onyebuchi E. Okosieme, MD, FRCP1; Colin M. Dayan, PhD, FRCP1
[+] Author Affiliations
1Thyroid Research Group, Institute of Molecular Medicine, Cardiff University School of Medicine, Cardiff, Wales
JAMA Intern Med. 2015;175(3):466-467. doi:10.1001/jamainternmed.2014.7862.
Text Size: A A A
Published online

Extract

In Reply Braithwaite and Moore have correctly identified in their recent letter that development of a suppressed thyrotropin (TSH) level following initiation of levothyroxine therapy may occur due to subsequent development of hyperthyroidism including Graves or toxic multinodular goiter rather than simply overtreatment. The conversion of autoimmune hypothyroidism to hyperthyroidism does occur; the exact frequency of this event is unknown but likely to be rare, and such events are still reported in the “unusual” case literature.1 They are therefore right to highlight that both adequate long-term TSH monitoring during levothyroxine therapy and patient education on the symptoms of hyperthyroidism are needed to reduce the risk of TSH suppression. However, we believe that subsequent development of noniatrogenic hyperthyroidism would only account for a small proportion of the suppressed TSH levels observed in our data set. Our data set excluded anyone who ever had a diagnosis of Graves disease, multinodular goiter, or thyroiditis (including postpartum), as well as anyone who ever required antithyroid drugs, radioiodine, or surgery, even after levothyroxine therapy initiation. Therefore, any individual developing noniatrogenic hyperthyroidism after levothyroxine therapy initiation would have had to have been unrecognized by health professionals over several years and therefore is likely to represent only a small number of individuals.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

March 1, 2015
Susan S. Braithwaite, MD; Justin B. Moore, MD
1Division of Endocrinology, Department of Internal Medicine, University of Illinois at Chicago
2Department of Internal Medicine, University of Kansas School of Medicine–Wichita
JAMA Intern Med. 2015;175(3):465-466. doi:10.1001/jamainternmed.2014.7841.
March 1, 2015
Oscar M. P. Jolobe, MRCP(UK), DPhil
1Manchester Medical Association, Manchester, England
JAMA Intern Med. 2015;175(3):466. doi:10.1001/jamainternmed.2014.7847.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

212 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();